BridgeBio Pharma
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$722.7M
Focus Areas
5
Top Stage
Preclinical/Early Clinical
Portfolio Companies
| Company | Valuation |
|---|---|
| BridgeBio Oncology Therapeutics | $722.7M |
| CoA Therapeutics | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| BridgeBio Oncology Therapeutics | $722.7M |
| CoA Therapeutics | — |